Alnylam Pharmaceuticals · 22 hours ago
Executive Director, Head of Business Development Transactions
Cambridge, MA
Full-time
Hybrid
Director/Executive
$280K/yr - $380K/yr
10+ years expAlnylam Pharmaceuticals is a leader in RNAi therapeutics, seeking an experienced Executive Director, Head of Business Development Transactions. The role involves providing transaction leadership in conducting business analyses, structuring complex deals, and collaborating with cross-functional teams to drive strategic business development initiatives.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Hiring Manager
Jill Donovan
Responsibilities
Demonstrate leadership and business acumen while collaborating closely with cross-functional teams including R&D, Commercial, Finance, Legal, and Search & Evaluation to evaluate external innovation including leading development of business cases and term sheets, cross-functional due diligence, and contract negotiations to execute strategic transactions in support of BD opportunity review, prioritization, and decision-making
Develop and recommend proposed deal structure and terms, utilizing an in-depth knowledge industry deal-making trends and co-lead, with the senior S&E / R&D / Commercial / Legal / Finance Leads, the delivery of business assessments and recommendations of external opportunities, including deal proposals, valuation, deal status, and key issues of the transaction to Alnylam governance bodies for endorsement
Lead or coach team members to negotiate deals, find solutions to bridge gap(s) when needed, communicate key deal issues, risks, and updates to leadership and senior internal stakeholders, review and provide comments to term sheets and contracts drafted by the Legal team to make sure they reflect business intent
Serve as thought partner to facilitate and support formulation of BD strategies to drive toward enterprise goals and objectives while sourcing and evaluating external innovation
Communicate effectively both internally across a matrix organization and externally with potential partners by articulating the vision, purpose, and expectations of the BD initiatives to ensure clarity and alignment
As part of the BD Leadership Team, manage or coach a team of BD professionals and foster a culture of excellence, innovation, and collaboration
Qualification
Required
At least 10+ years of relevant industry experience in biotechnology and pharmaceutical BD, in particular, transactions function with a significant number of closed deals, including experience in leading multiple complex and high-value transactions. Deal sheet specifics required
Deep understanding of the drug development processes and extensive knowledge of biotechnology and pharmaceutical industries including market trends, regulatory environment, the macro deal making environment, and their business impact
Proven ability to integrate scientific knowledge into business case to analyze and understand commercial forecasts, P&Ls, risk analyses, and other financial valuations techniques and strong term sheet / contract negotiation skills
Demonstrated ability to simplify complex ideas / concepts, synthesize and summarize a complex set of facts and opportunities within the broader strategic context as well as proven track record to exert influence, facilitate candid dialogue find solutions and gain alignment
Excellent communication, presentation, and problem-solving skills, with the proven ability to influence and persuade internal and external stakeholders at all levels
Highly collaborative, team-oriented, and adaptable, with the ability to work effectively in a fast-paced and dynamic environment
Proven ability to manage multiple projects efficiently with a high degree of independence and purposed urgency
Strong executive presence, leadership, and people management skills, with the ability to inspire and motivate others
Preferred
MBA, JD, or other advanced business degrees with a background in science preferred
Must have an aptitude to quickly understand new science and technology
Benefits
Medical, dental, and vision coverage
Life and disability insurance
Lifestyle reimbursement program
Flexible spending and health savings accounts
401(k) with a generous company match
Paid time off
Wellness days
Holidays
Two company-wide recharge breaks
Generous family resources and leave
Company
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
1001-5000 employees
H1B Sponsorship
Alnylam Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2022 (18)
2021 (19)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$4.55BKey Investors
Blackstone Life SciencesBlackstone CreditRegeneron
2025-09-09Post Ipo Debt· $661.25M
2022-09-12Post Ipo Debt· $900M
2022-03-04IPO
Leadership Team
Yvonne Greenstreet
Chief Executive Officer
Jeff Poulton
Chief Financial Officer
Recent News
2025-12-22
2025-12-20
Company data provided by crunchbase